Brightspring health services announces onco360® selected as national pharmacy partner for multiple new cancer and rare disease drugs

Louisville, ky., june 18, 2025 (globe newswire) -- brightspring health services (“brightspring” or “brightspring health services”) (nasdaq: btsg) is proud to announce that its specialty pharmacy, onco360®, has been selected as the national pharmacy partner for several newly approved therapies in the treatment of advanced cancers and rare genetic disorders.
BTSG Ratings Summary
BTSG Quant Ranking